Image
Stories
Mid-large buyout
Investments
We offer everything our portfolio companies need to grow: the insights of our committed experts, in-depth industry knowledge, prime access to global markets and a responsible approach to value creation. We have developed a diversified portfolio across various sectors of activity, including today’s top performers and the unicorns and leaders of tomorrow. It is built for success in both the short and long term.
Non-exhaustive portfolio.
Stories
Blocs de la page
244 result(s)
244 result(s)
Pharvaris
Rare disease treatment
Healthcare - Kurma Partners
StatusIn portfolio
Investment date07/2020
SectorHealthcare
LocationEurope
Thought Machine
Supplier of next generation, cloud native core banking systems
Growth
StatusIn portfolio
Investment date07/2020
SectorFinancial Services
LocationEurope
Waterloo Sparkling Waters
Producer and distributor of sparkling water
StatusIn portfolio
Investment date08/2020
SectorConsumer
LocationNorth America
Amolyt Pharma
Company developing drugs to treat rare diseases
Healthcare - Kurma Partners
StatusIn portfolio
Investment date08/2020
SectorHealthcare
LocationEurope
Ermium
Drug discovery of novel anti-inflammatory drugs
Healthcare - Kurma Partners
StatusIn portfolio
Investment date09/2020
SectorHealthcare
LocationEurope
UTAC
European leader in vehicle development testing and certification
Elevate
StatusIn portfolio
Investment date09/2020
SectorTech-enabled
LocationEurope
Information - Individual investors
Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)